Salvage surgery following downstaging of unresectable hepatocellular carcinoma - A strategy to increase resectability

被引:205
作者
Lau, Wan Yee [1 ]
Lai, Eric C. H. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Peoples R China
关键词
hepatocellular carcinoma; tumor downstaging; hepatectomy; therapeutic embolization; salvage surgery;
D O I
10.1245/s10434-007-9549-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Surgical resection with complete extirpation of the tumor gives the best chance of a cure for patients with hepatocellular carcinoma (HCC). However, the resectability of HCC at the time of diagnosis is low (10-30%). This article reviews the use of salvage surgery following tumor downstaging to treat unresectable HCC. Materials and methods: A Medline search was undertaken from 1966 to 2005 to identify articles using the keywords "liver neoplasm," "hepatocellular carcinoma," "tumor downstaging," and "unresectable." Additional papers were identified by a manual search of the references from the key articles. Results: Eight to eighteen percent of patients with unresectable HCC responded well enough to the initial palliative treatment to downstage HCC to allow salvage surgical resection. The reported five-year survival rate after salvage surgery following tumor downstaging varied from 24.9 to 57%. Conclusions: Although it is still unknown whether the outcome of salvage surgery following tumor downstaging is comparable to those of resectable tumors after primary resection, one clear message is that salvage surgery following tumor downstaging gives good long-term results and the possibility of a cure in a proportion of patients with unresectable HCC. The role of salvage surgery after tumor downstaging in improving disease-free and overall survival in patients with unresectable HCC should be investigated further by prospective randomized controlled trials.
引用
收藏
页码:3301 / 3309
页数:9
相关论文
共 52 条
[1]
Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16
[2]
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [J].
Bismuth, H ;
Adam, R ;
Levi, F ;
Farabos, C ;
Waechter, F ;
Castaing, D ;
Majno, P ;
Engerran, L .
ANNALS OF SURGERY, 1996, 224 (04) :509-520
[3]
Undifferentiated sarcoma of the liver in childhood - A curable disease [J].
Bisogno, G ;
Pilz, T ;
Perilongo, G ;
Ferrari, A ;
Harms, D ;
Ninfo, V ;
Treuner, J ;
Carli, M .
CANCER, 2002, 94 (01) :252-257
[4]
*CAN TASK FORC, LEV EV
[5]
Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[6]
Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy [J].
Clavien, PA ;
Selzner, N ;
Morse, M ;
Selzner, M ;
Paulson, E .
SURGERY, 2002, 131 (04) :433-442
[7]
THE THIRD INTERGROUP RHABDOMYOSARCOMA STUDY [J].
CRIST, W ;
GEHAN, EA ;
RAGAB, AH ;
DICKMAN, PS ;
DONALDSON, SS ;
FRYER, C ;
HAMMOND, D ;
HAYS, DM ;
HERRMANN, J ;
HEYN, R ;
JONES, PM ;
LAWRENCE, W ;
NEWTON, W ;
ORTEGA, J ;
RANEY, RB ;
RUYMANN, FB ;
TEFFT, M ;
WEBBER, B ;
WIENER, E ;
WHARAM, M ;
VIETTI, TJ ;
MAURER, HM .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :610-630
[8]
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[9]
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].
Douillard, JY ;
Cunningham, D ;
Roth, AD ;
Navarro, M ;
James, RD ;
Karasek, P ;
Jandik, P ;
Iveson, T ;
Carmichael, J ;
Alakl, M ;
Gruia, G ;
Awad, L ;
Rougier, P .
LANCET, 2000, 355 (9209) :1041-1047
[10]
Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma [J].
Fan, J ;
Tang, ZY ;
Yu, YQ ;
Wu, ZQ ;
Ma, ZC ;
Zhou, XD ;
Zhou, J ;
Qiu, SJ ;
Lu, JZ .
DIGESTIVE SURGERY, 1998, 15 (06) :674-678